WallStSmart

Ventas Inc (VTR)vsChiron Real Estate Inc. (XRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 4136% more annual revenue ($6.42B vs $151.53M). VTR leads profitability with a 4.1% profit margin vs -5.1%. VTR appears more attractively valued with a PEG of 1.74. XRN earns a higher WallStSmart Score of 45/100 (D+).

VTR

Hold

45

out of 100

Grade: D+

Growth: 6.0Profit: 4.5Value: 2.7Quality: 4.0
Piotroski: 4/9Altman Z: 0.43

XRN

Hold

45

out of 100

Grade: D+

Growth: 5.3Profit: 4.0Value: 4.0Quality: 3.5
Piotroski: 4/9Altman Z: -0.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VTRSignificantly Overvalued (-21.9%)

Margin of Safety

-21.9%

Fair Value

$76.69

Current Price

$90.84

$14.15 premium

UndervaluedFair: $76.69Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VTR1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

XRN2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
23.4%8/10

Strong operational efficiency at 23.4%

Areas to Watch

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

P/E RatioValuation
170.0x2/10

Premium valuation, high expectations priced in

XRN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$580.67M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.353/10

Elevated debt levels

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : VTR

The strongest argument for VTR centers on Revenue Growth. Revenue growth of 21.7% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on Price/Book, Operating Margin. Revenue growth of 10.1% demonstrates continued momentum.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 170.0x leaves little room for execution misses. Thin 4.1% margins leave little buffer for downturns.

Bear Case : XRN

The primary concerns for XRN are EPS Growth, Market Cap, Debt/Equity.

Key Dynamics to Monitor

VTR profiles as a growth stock while XRN is a turnaround play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.12 — expect wider price swings.

VTR is growing revenue faster at 21.7% — sustainability is the question.

XRN generates stronger free cash flow (11M), providing more financial flexibility.

Bottom Line

VTR scores higher overall (45/100 vs 45/100) and 21.7% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?